SavedAdd your journal

Journals / Clinical and Experimental Health Sciences / 2019 / Cilt: 9 - Sayı: 3

Association Between Onychomycosis and Foot Ulcers in Patients with Diabetes Mellitus

Haci Hasan ABUOGLU
Emre GUNAY
Sevil OZKAN
Hakan UZUNOGLU
Riza ADALETİ
Cebrail AKYUZ
Bulent KAYA
Pages
261–264
Publication Date
2019-09-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

By treating onychomycosis early, foot amputation can be prevented

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Diabetes mellitus (DM) is associated with many serious health complications such as diabetic foot ulcer (DFU).
📊
Key Findings & Data:Onychomycosis increases the risk for foot disorders and limb amputation in DM patients, and if untreated, can result in tissue degradation and DFU.
💡
Conclusion & Impact:By treating onychomycosis early, foot amputation can be prevented
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Diabetes Mellitus · Diabetic Foot · Risk Factors

Abstract

Objective: Diabetes mellitus (DM) is associated with many serious health complications such as diabetic foot ulcer (DFU). Onychomycosis increases the risk for foot disorders and limb amputation in DM patients, and if untreated, can result in tissue degradation and DFU. Therefore, this study aimed to determine the association between the incidences of onychomycosis and DFU.Methods: This study included 40 DM patients with DFU (study group) and 40 DM patients without FU (control group). Samples were obtained from the most affected part of the nail. The deep-nail plaque of the right toe was preferred in patients with normal toenail appearance. In addition, mycological examinations were conducted. Values of p<0.01 were considered as significant.Results: No significant difference was observed between the two groups with respect to age, sex, and hemoglobin A1c levels (p<0.01). However, the incidence of onychomycosis and use of insulin were significantly higher in the study group than in the control group (p<0.01 and p<0.001, respectively).Conclusion: Onychomycosis might be associated with development of FU in patients with DM. By treating onychomycosis early, foot amputation can be prevented

🔖

Cite This Article

ABUOGLU, H. H., GUNAY, E., OZKAN, S., UZUNOGLU, H., ADALETİ, R., AKYUZ, C., KAYA, B. (2019). Association Between Onychomycosis and Foot Ulcers in Patients with Diabetes Mellitus. Clinical and Experimental Health Sciences, Cilt: 9 - Sayı: 3, 261–264. https://ajindex.com/articles/481628

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diab Res Clin Pract. 2010
  2. 87(1):4-14. 2. İşçimen A, Arzuhal N. Cutaneus findings of diabetes mellitus. Dermatose. 2004
  3. Yosipovitch G, Hodak E, Vardi P, Shraga I, Karp M, Sprecher E, David M. The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications. Diabetes Care. 1998
  4. 21(6):506-509. 4. Aşçı Z, Seyrek A, Kizirgil A, Yılmaz M. Tinea unguium investigated in patients with diabetes. Turk J Infect. 1996
  5. Jaffe R. Onychomycozis: recognition, diagnosis, and management. Arch Fam Med. 1998
  6. Kiraz M, Yeğenoğlu Y, Erturan Z. The epidemiology of onychomycoses in Istanbul, Turkey. Mycoses. 1999
  7. 42(4):323-329. 7. Ilkit M. Onychomycosis in Adana, Turkey: a 5-year study. Int J Dermatol. 2005
  8. Segal R, Kimchi A, Kritzman A, Inbar R, Segal Z. The frequency of Candida parapsilosis in onychomycosis. An epidemiological survey in Israel. Mycoses. 2000
  9. 43(9-10):349-353. 9. Tabatabaei-Malazy O, Mohajeri-Tehrani MR, Pajouhi M, Shojaei Fard A, Amini MR, Larijani B. Iranian diabetic foot research network. Adv Skin Wound Care. 2010
  10. Marston W. A.
  11. Dermagraft Diabetic Foot Ulcer Study Group. Risk factors associated with healing chronic diabetic foot ulcers: the importance of hyperglycemia. Ostomy. Wound. Manage. 2006
  12. 52(3):26-29. 11. Reiber GE, Vileikyte L, Boyko E. J, del Aguila M, Smith DG, Lavery LA, Boulton AJ. Causal pathways for incident lower extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999
  13. 22(1): 157-162. 12. Gupta AK, Konnikov N, MacDonald P, Rich P, Rodger NW, Edmonds MW, McManus R, Summerbell RC. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol. 1998
  14. 139(4):665-671. 13. Gupta AK, Humke S. The prevalence and management of onychomycosis in diabetic patients. Eur J Dermatol. 2000
  15. 10(5):379-384. 14. Mayser P, Hensel J, Thoma W, Podobinska M, Geiger M, Ulbricht H, Haak T. Prevalence of fungal foot infections in patients with diabetes mellitus type 1-underestimation of moccasin-type tinea. Exp Clin Endocrinol Diabetes. 2004
  16. 112(5):264-268. 15. Rich P. Special patient populations: onychomycosis in the diabetic patient. J Am Acad Dermatol. 1996
  17. 35(3):10-12. 16. Boulton A, Vinik A, Arezzo J, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, So